Earnings Feed
Start Free
Home/Filings/4/0001140361-11-031986
4//SEC Filing

McIntosh David M 4

Accession 0001140361-11-031986

CIK 0001228627other
View on SEC.govCompany Profile

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 5:08 PM ET

Size

15.4 KB

Accession

0001140361-11-031986

Insider Transaction Report

Form 4
Period: 2011-06-06
REXAHN PHARMACEUTICALS, INC.RNN
McIntosh David M
Director
Transactions
  • Award

    Stock Options (right-to-buy)

    2011-06-06+20,000→ 20,000 total
    Exercise: $1.25Exp: 2021-06-06→ Common Stock (20,000 underlying)
Holdings

  • Stock Options (right-to-buy)

    Exercise: $1.17Exp: 2020-06-14→ Common Stock (20,000 underlying)
    20,000

  • Common Stock

    (indirect: By son)
    2,800

  • Stock Options (right-to-buy)

    Exercise: $0.80From: 2007-04-20Exp: 2014-04-20→ Common Stock (125,000 underlying)
    125,000
Footnotes (2)
  • [F1]These options vest and become exercisable in full on June 06, 2012
  • [F2]These options vest and become exercisable in full on June 14, 2011.

Documents

1 file

Issuer

REXAHN PHARMACEUTICALS, INC.

CIK 0001228627

→
Entity typeother

Related Parties

1
  • filerCIK 0001317248

Filing Metadata

Form type
4
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 5:08 PM ET
Size
15.4 KB
View on SEC.gov